Acute heart failure with accompanying chronic obstructive pulmonary disease: Should we focus on beta blockers?

Background Acute heart failure (AHF) with systolic dysfunction is associated with increased morbidity and mortality, and optimal therapy is not well established, despite the findings of evidence-based medicine. Beta blockers provide a mortality and morbidity benefit in patients with chronic systolic...

Ausführliche Beschreibung